2010

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.
Hemmati, P.G., Terwey, T.H., Massenkeil, G., le Coutre, P., Vuong, L.G., Neuburger, S., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and Arnold, R.
International Journal of Hematology 91 (3): 436-445. April 2010

2008

Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.
Weisel, K.C., Weidmann, E., Anagnostopoulos, I., Kanz, L., Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Subklewe, M.
International Journal of Hematology 88 (4): 434-440. November 2008

2005

CD52 is not a promising immunotherapy target for most patients with multiple myeloma.
Westermann, J., Maschmeyer, G., Lessen, A., Doerken, B. ORCID: https://orcid.org/0000-0001-7991-3643 and Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470
International Journal of Hematology 82 : 248-250. 1 October 2005

Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.
Koschmieder, S., Rosenbauer, F. ORCID: https://orcid.org/0000-0001-7977-9421, Steidl, U., Owens, B.M. and Tenen, D.G.
International Journal of Hematology 81 : 368-377. 1 June 2005

2000

Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?
Buechner, T., Hiddemann, W., Woermann, B., Loeffler, H., Ludwig, W.D., Schoch, C., Haferlach, T., Maschmeyer, G., Staib, P., Aul, C., Heyll, G.A., Gruneisen, A., Rasche, H., Eimermacher, J.H., Balleisen, L., Pielken, H.J., Reis, H.E., Griesinger, F., Reichle, A., Sauerland, M.C. and Heinecke, A.
International Journal of Hematology 72 : 285-289. 1 October 2000